EMCDDA highlights new health risks as products and patterns of use change
Europe’s drug market remains resilient, says the EU drugs agency (EMCDDA) today as it launches in Lisbon its European Drug Report 2016: Trends and Developments,
EUROPEAN DRUG REPORT 2016 — HIGHLIGHTS 31.05.2016
Čtěte více